Bioheart, Inc. , a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage, has enhanced its resources with the addition of two service providers on its team -- Outside Eyes and Mitrani, Rynor, Adamsky & ... (more)
http://www.biospace.com/news_story.aspx?StoryID=310227&full=1
http://www.biospace.com/news_story.aspx?StoryID=310227&full=1
No comments:
Post a Comment